|
Endometrial Studies
A Phase III Open Label, Randomized, 2 Arm Study of Ixabepilone Administered Every 21 Days Versus Paclitaxel or Doxorubicin Administered Every 21 Days in Women with Advanced Endometrial Cancer Who Have Previously Been Treated with Chemotherapy.(CA163196):
- Histologic or cytologic diagnosis of endometrial carcinoma
- Evidence that cancer is locally advanced, recurrent or metastatic and not curable by local measures (ie, surgery, radiation)
|
Sparrow Regional Cancer Center: Research & Clinical Trials
|
